• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Cell-type-specific role of STAT3 in non-alcoholic steathepatitis

Research Project

Project/Area Number 22790631
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Gastroenterology
Research InstitutionGunma University

Principal Investigator

HORIGUCHI Norio  群馬大学, 医学部, 助教 (10550022)

Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords非アルコール性脂肪性肝炎 / STAT3 / メチオニンコリン欠乏食 / 細胞特異 / 細胞特異性 / SREBP1 / NASH / 炎症細胞 / IL-10 / MCD食 / 高脂肪食 / 非アルコール性脂肪性肝炎(NASH) / 脂質沈着 / SREBP1c / ノックアウトマウス
Research Abstract

The cell type specific role of STAT3 was examined by using hepatocyte-specific STAT3 knockout mice and macrophage/neutrophil specific STAT3 knockout mice. Both knockout mice and control wild type mice were fed with methionine-choline deficient diet, which is a murine NASH model. We have shown activation of STAT3 in hepatocyte prevents steatosis by inhibiting SREBP1c activation. On the other hand, we have revealed activation of STAT3 in macrophage/neutrophil accelerates inflammation in the liver, while it prevents steatosis by STAT3 activation in hepatocytes.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (36 results)

All 2013 2012 2011 2010 Other

All Journal Article (28 results) (of which Peer Reviewed: 28 results) Presentation (8 results)

  • [Journal Article] A proscetive study of long-term outcomes in female patietnts with nonalcoholic steatohepatitis using age-and body mass index-matched cohorts.2013

    • Author(s)
      Hashizume H
    • Journal Title

      Acta med Okayama

      Volume: 67 Pages: 45-53

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor promotes lung carcinogenesis in transgenic mice treated with diethylnitrosamine2013

    • Author(s)
      Kojima A
    • Journal Title

      Anticancer Res

      Volume: Anticancer Res Pages: 895-901

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cytokines and STATs in Liver Fibrosis2012

    • Author(s)
      Kong X, Horiguchi N, (他2名)
    • Journal Title

      Front Physiol

      Volume: 3 Pages: 69-69

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Ligand dependent hepatic gene expression profiles of nuclear receptors CAR and PXR2012

    • Author(s)
      Tojima H, Kakizaki S, Yamazaki Y, Takizawa D, Horiguchi N,(他2名)
    • Journal Title

      Toxicol Lett

      Volume: 212 Pages: 288-97

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Response-guidedpeginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads2012

    • Author(s)
      Sato K, Hashizume H, Yamazaki Y, Horiguchi N, Kakizaki S, (他1名)
    • Journal Title

      Hepatol Res

      Volume: 42 Pages: 854-63

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Optimal follow-up time to determine the sustained virologicalresponse in patients with chronic hepatitis C receivingpegylated-interferon and ribavirin2012

    • Author(s)
      Namikawa M, Kakizaki S, Yata Y, Yamazaki Y, Horiguchi N, (他3名)
    • Journal Title

      J Gastroenterol Hepatol

      Volume: 27 Pages: 69-75

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence2012

    • Author(s)
      Ohyama T, Sato K, Kishimoto K, Yamazaki Y, Horiguchi N, (他5名)
    • Journal Title

      Br J Pharmacol

      Volume: 165 Pages: 1173-87

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving Peg-IFN and ribavirin2012

    • Author(s)
      Namikawa M, Kakizaki S, Yata Y, Yamazaki Y, Horiguchi N, (他3名)
    • Journal Title

      J Gastroenterol Hepatol

      Volume: 27 Pages: 69-75

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Cytokines and STATs in Liver Fibrosis2012

    • Author(s)
      Kong X
    • Journal Title

      Front Physiol.

      Volume: 3 Pages: 69-69

    • DOI

      10.3389/fphys.2012.00069

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines2011

    • Author(s)
      Miller AM, Horiguchi N, (他3名)
    • Journal Title

      Alcohol Clin Exp Res

      Volume: 35 Pages: 787-93

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Inflammation-associated IL-6/STAT3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in IL-10 deficient mice2011

    • Author(s)
      Miller AM, Wang H, Bertola A, Park O, Horiguchi N,(他4名)
    • Journal Title

      Hepatology

      Volume: 54 Pages: 846-56

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis2011

    • Author(s)
      Takizawa D, Kakizaki S, Horiguchi N, (他3名)
    • Journal Title

      Carcinogenesis

      Volume: 32 Pages: 576-83

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Clinical characteristics of null responders toPeg-IFNα2b/ribavirin therapy for chronic hepatitis C2011

    • Author(s)
      Suzuki H, Kakizaki S, Horiguchi N, (他4名)
    • Journal Title

      World J Hepatol

      Volume: 27;2 Pages: 401-5

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-12011

    • Author(s)
      Ohyama T, Yamazaki Y, Sato K, Horiguchi N, Ichikawa T, Kakizaki S, (他4名)
    • Journal Title

      Liver Int

      Volume: 31 Pages: 572-84

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice2011

    • Author(s)
      Miller, et al.
    • Journal Title

      Hepatology

      Volume: 54 Issue: 3 Pages: 846-56

    • DOI

      10.1002/hep.24517

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Molecular mechanisms of alcoholic liver disease : innate immunity and cytokines2011

    • Author(s)
      Miller, et al.
    • Journal Title

      Alcohol Clin Exp Res

      Volume: 35 Issue: 5 Pages: 787-93

    • DOI

      10.1111/j.1530-0277.2010.01399.x

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis2011

    • Author(s)
      Tojima H, Kakizaki S, et al.
    • Journal Title

      Hepatol Int

      Volume: (印刷中) Issue: 3 Pages: 620-630

    • DOI

      10.1007/s12072-011-9301-z

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Transforming growth factor-α attenuates hepatic fibrosis : possible involvement of matrix metalloproteinase-1.2011

    • Author(s)
      Ohyama, et al
    • Journal Title

      Liver International

      Volume: 31 Pages: 572-84

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice2010

    • Author(s)
      Horiguchi N, (他9名)
    • Journal Title

      Hepatology

      Volume: 51 Pages: 1724-34

    • Related Report
      2012 Final Research Report 2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Histone deacetylase inhibitors induce cytochrome P450 2B by activating nuclear receptor constitutive androstane receptor2010

    • Author(s)
      Takizawa D, Kakizaki S, Horiguchi N, (他5名)
    • Journal Title

      Drug Metab Dispos

      Volume: 38 Pages: 1493-8

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Anti-Inflammatory and Anti-Apoptotic Roles of Endothelial Cell STAT3 in Alcoholic Liver Injury2010

    • Author(s)
      Miller AM, Wang H, Park O, Horiguchi N, (他7名)
    • Journal Title

      Alcohol Clin Exp Res

      Volume: 34 Pages: 719-25

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury.2010

    • Author(s)
      Miller, et al.
    • Journal Title

      Alcohol Clin Exp Res

      Volume: 34 Pages: 719-25

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity.2010

    • Author(s)
      Wang, et al.
    • Journal Title

      Hepatology

      Volume: 51 Pages: 1354-62

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Histone deacetylase inhibitors induce cytochrome P450 2B by activating nuclear receptor constitutive androstane receptor.2010

    • Author(s)
      Takizawa, et al.
    • Journal Title

      Drug Metab Dispos

      Volume: 38 Pages: 1493-8

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis.2010

    • Author(s)
      Takizawa, et al.
    • Journal Title

      Carcinogenesis

      Volume: 32 Pages: 576-83

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C.2010

    • Author(s)
      Suzuki, et al.
    • Journal Title

      World J Hepatol.

      Volume: 27 Pages: 401-5

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis

    • Author(s)
      Tojima H, Kakizaki S, Kosone T, Horiguchi N, (他4名)
    • Journal Title

      Hepatol Int

      Volume: (in press)

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Interplay of hepatic and myeloid signal transducer and activator oftranscription 3 in facilitating liver regeneration via tempering innate immunity

    • Author(s)
      Wang H, Park O, Lafdil F, Shen K, Horiguchi N, (他4名)
    • Journal Title

      Hepatology

      Volume: 51 Pages: 1354-62

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Presentation] マウスアルコール性脂肪性肝炎における細胞特異的なSTAT3の役割2013

    • Author(s)
      堀口 他
    • Organizer
      第32回アルコール医学生物研究会学術集会
    • Place of Presentation
      東京都市センター
    • Related Report
      2012 Final Research Report
  • [Presentation] マウスアルコール性脂肪性肝炎モデルにおける細胞特異的なSTAT3の役割2013

    • Author(s)
      堀口 昇男
    • Organizer
      第32回アルコール医学生物学研究会学術集会
    • Place of Presentation
      東京 都市センター
    • Related Report
      2012 Annual Research Report
  • [Presentation] Macrophage Migration Inhibitory factor(MIF) attenuates liver inflammation, steatosis, and fibrosis in murine non-alcoholic liver disease model2012

    • Author(s)
      Horiguchi et al
    • Organizer
      第51回米国消化器病学会週間
    • Place of Presentation
      San Diego, U.S.A.
    • Related Report
      2012 Final Research Report
  • [Presentation] Macrophage migration inhibitory factor (MIF) attenuates liver inflammamtion, steatosis, and fibrosis in murine non-alcoholic liver disease model2012

    • Author(s)
      Horiguchi N
    • Organizer
      Digestive Disease Week
    • Place of Presentation
      San Diego, U.S.A.
    • Related Report
      2012 Annual Research Report
  • [Presentation] Myeloid細胞特異的STAT3ノックアウトマウスでは、四塩化炭素肝炎モデルにおいて肝炎症細胞浸潤と肝障害が乖離する2011

    • Author(s)
      堀口昇男
    • Organizer
      第47回 日本肝臓学会総会
    • Place of Presentation
      東京:ホテルパシフィックLe Daiba
    • Related Report
      2011 Annual Research Report
  • [Presentation] アルコール性脂肪性肝炎における細胞特異的なSTAT3の役割2011

    • Author(s)
      堀口昇男
    • Organizer
      第97回 日本消化器病学会総会
    • Place of Presentation
      東京:京王プラザ
    • Related Report
      2011 Annual Research Report
  • [Presentation] 四塩化炭素肝炎モデルにおけるMyeloid細胞特異的STAT3の役割2010

    • Author(s)
      堀口昇男
    • Organizer
      第46回 日本肝臓学会総会
    • Place of Presentation
      山形
    • Related Report
      2010 Annual Research Report
  • [Presentation] HGF promotes DEN-induced hepatocarcinogenesis, but attenuates MCD-induced liver inflammation and fibrosis2010

    • Author(s)
      Horiguchi, et al.
    • Organizer
      2010年 米国肝臓学会議(AASLD2010)
    • Place of Presentation
      米国 ボストン
    • Related Report
      2010 Annual Research Report

URL: 

Published: 2010-08-23   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi